María Patricia Hernández-Mitre

University Of Queensland Centre for Clinical Research

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (7)

Jason A Roberts

University Of Queensland Centre for Clinical Research

AUSTRALIA

View details

Robert Medcalf

Professor

Monash University Central Clinical School

AUSTRALIA

View details

James Totterdell

University of Sydney

AUSTRALIA

View details

Xin Liu

University of Queensland

AUSTRALIA

View details

Suzanne Parker

University of Queensland

AUSTRALIA

View details

Bala Venkatesh

Academic Professor of Intensive Care

Gold Coast University Hospital

AUSTRALIA

View details

Fekade B Sime

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

María Patricia Hernández-Mitre

Research Interests

Explore related searches

Contact this professor

Articles (10)

Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects

Optimizing ICU antifungal therapy: overcoming pharmacokinetic limitations with combination strategies—author's reply

Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study

A pharmacokinetic/pharmacodynamic analysis of intravenous tranexamic acid in adult patients undergoing elective total hip arthroplasty (ORACLE)

Population pharmacokinetics of prophylactic cefoxitin in elective bariatric surgery patients: a prospective monocentric study

TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate.

Propofol and Fentanyl Pharmacokinetics and Pharmacodynamics in Extracorporeal Membrane Oxygenation

A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects

Stability of nafamostat in intravenous infusion solutions, human whole blood and extracted plasma: implications for clinical effectiveness studies

A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study

Collaborators (7)

Jason A Roberts

Robert Medcalf

James Totterdell

Xin Liu

Suzanne Parker

Bala Venkatesh

Fekade B Sime

Make your next move.